Pages that link to "Q35811715"

The following pages link to Serum antibody response to five Streptococcus pneumoniae proteins during acute otitis media in otitis-prone and non-otitis-prone children (Q35811715):

Displaying 45 items.

• The host immune dynamics of pneumococcal colonization: implications for novel vaccine development (Q28084920) (← links)
• Contributions to protection from Streptococcus pneumoniae infection using the monovalent recombinant protein vaccine candidates PcpA, PhtD, and PlyD1 in an infant murine model during challenge (Q34057765) (← links)
• Differential impact of respiratory syncytial virus and parainfluenza virus on the frequency of acute otitis media is explained by lower adaptive and innate immune responses in otitis-prone children (Q34137781) (← links)
• Prevalence and clonal distribution of pcpA, psrP and Pilus-1 among pediatric isolates of Streptococcus pneumoniae. (Q34358647) (← links)
• IgG responses to Pneumococcal and Haemophilus influenzae protein antigens are not impaired in children with a history of recurrent acute otitis media. (Q34477702) (← links)
• Dynamics of Streptococcus pneumoniae serotypes causing acute otitis media isolated from children with spontaneous middle-ear drainage over a 12-year period (1999-2010) in a region of northern Spain (Q34562927) (← links)
• Human antibodies to PhtD, PcpA, and Ply reduce adherence to human lung epithelial cells and murine nasopharyngeal colonization by Streptococcus pneumoniae (Q34595710) (← links)
• Synchrony in serum antibody response to conserved proteins of Streptococcus pneumoniae in young children (Q35887453) (← links)
• Naturally Acquired Human Immunity to Pneumococcus Is Dependent on Antibody to Protein Antigens (Q36263931) (← links)
• Panel 5: Immunology (Q36333073) (← links)
• Vaccine candidates PhtD and PhtE of Streptococcus pneumoniae are adhesins that elicit functional antibodies in humans (Q36376010) (← links)
• Nasopharyngeal bacterial interactions in children (Q36574329) (← links)
• Antibody response to Streptococcus pneumoniae proteins PhtD, LytB, PcpA, PhtE and Ply after nasopharyngeal colonization and acute otitis media in children (Q36920037) (← links)
• Functional Immune Cell Differences Associated With Low Vaccine Responses in Infants (Q36931781) (← links)
• Next generation protein based Streptococcus pneumoniae vaccines (Q37130191) (← links)
• Novel role for the Streptococcus pneumoniae toxin pneumolysin in the assembly of biofilms (Q37174555) (← links)
• CD4 T cell memory and antibody responses directed against the pneumococcal histidine triad proteins PhtD and PhtE following nasopharyngeal colonization and immunization and their role in protection against pneumococcal colonization in mice (Q37264678) (← links)
• Differences in innate immune response gene regulation in the middle ear of children who are otitis prone and in those not otitis prone (Q37413576) (← links)
• Nonprotective responses to pediatric vaccines occur in children who are otitis prone (Q37448666) (← links)
• Lower nasopharyngeal epithelial cell repair and diminished innate inflammation responses contribute to the onset of acute otitis media in otitis-prone children. (Q37618725) (← links)
• Higher serum levels of interleukin 10 occur at onset of acute otitis media caused by Streptococcus pneumoniae compared to Haemophilus influenzae and Moraxella catarrhalis (Q37664290) (← links)
• Otitis-Prone Children Produce Functional Antibodies to Pneumolysin and Pneumococcal Polysaccharides. (Q37683735) (← links)
• Safety and immunogenicity of a pneumococcal histidine triad protein D vaccine candidate in adults (Q38058158) (← links)
• Safety and immunogenicity of the pneumococcal pneumolysin derivative PlyD1 in a single-antigen protein vaccine candidate in adults (Q38059914) (← links)
• Cellular immune response in young children accounts for recurrent acute otitis media (Q38136104) (← links)
• Challenges in vaccination of neonates, infants and young children (Q38212484) (← links)
• Epidemiology of Acute Otitis Media in the Postpneumococcal Conjugate Vaccine Era. (Q38636215) (← links)
• Ten-Year Study of the Stringently Defined Otitis-prone Child in Rochester, NY. (Q38858526) (← links)
• Developing a vaccine to prevent otitis media caused by nontypeable Haemophilus influenzae (Q38905937) (← links)
• Australian Aboriginal Children with Otitis Media Have Reduced Antibody Titers to Specific Nontypeable Haemophilus influenzae Vaccine Antigens (Q38984614) (← links)
• Role of antibodies and IL17-mediated immunity in protection against pneumococcal otitis media (Q39258723) (← links)
• PcpA of Streptococcus pneumoniae mediates adherence to nasopharyngeal and lung epithelial cells and elicits functional antibodies in humans (Q39314657) (← links)
• Modeling Specific Antibody Responses to Natural Immunization to Predict a Correlate of Protection Against Infection Before Commencing a Clinical Vaccine Trial (Q40053752) (← links)
• Stringently Defined Otitis Prone Children Demonstrate Deficient Naturally Induced Mucosal Antibody Response to Moraxella catarrhalis Proteins (Q40076683) (← links)
• Serum antibody response to Moraxella catarrhalis proteins in stringently defined otitis prone children (Q40114722) (← links)
• Safety, reactogenicity and immunogenicity of a novel pneumococcal protein-based vaccine in adults: a phase I/II randomized clinical study (Q40215132) (← links)
• Peripheral blood antigen presenting cell responses in otitis-prone and non-otitis-prone infants (Q40910398) (← links)
• Antibody in middle ear fluid of children originates predominantly from sera and nasopharyngeal secretions (Q41589432) (← links)
• Pneumococcal whole-cell and protein-based vaccines: changing the paradigm (Q47410739) (← links)
• Poor memory B cell generation contributes to non-protective responses to DTaP vaccine antigens in otitis-prone children (Q50724844) (← links)
• Divergent mucosal and systemic responses in children in response to acute otitis media. (Q51719687) (← links)
• Safety and immunogenicity of pneumococcal protein vaccine candidates: monovalent choline-binding protein A (PcpA) vaccine and bivalent PcpA-pneumococcal histidine triad protein D vaccine (Q85350626) (← links)
• Vaccination with a Streptococcus pneumoniae trivalent recombinant PcpA, PhtD and PlyD1 protein vaccine candidate protects against lethal pneumonia in an infant murine model (Q87680192) (← links)
• Panel 3: Genomics, precision medicine and targeted therapies (Q89481909) (← links)
• Immunologic Dysfunction Contributes to the Otitis Prone Condition (Q90602359) (← links)